Onclive articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Wed, 23 Apr 2014 12:02:46 EDT 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Experts Debate Utility of Genomic Profiling in Daily Practice]]>http://www.onclive.com/publications/Oncology-live/2014/April-2014/Experts-Debate-Utility-of-Genomic-Profiling-in-Daily-PracticeOnclive articlesusWed, 23 Apr 2014 09:12:51 EDTOnclive<![CDATA[Novartis Plans Acquisition of GSK’s Oncology Products]]>http://www.onclive.com/web-exclusives/Novartis-Plans-Acquisition-of-GSKs-Oncology-ProductsOnclive articlesusTue, 22 Apr 2014 16:09:59 EDTOnclive<![CDATA[Long-Term Outcomes Support Sentinel-Node Biopsy for Staging Melanoma]]>http://www.onclive.com/publications/Oncology-live/2014/April-2014/Long-Term-Outcomes-Support-Sentinel-Node-Biopsy-for-Staging-MelanomaOnclive articlesusTue, 22 Apr 2014 08:45:29 EDTOnclive<![CDATA[FDA Approves Ramucirumab for Gastric and GEJ Adenocarcinoma]]>http://www.onclive.com/web-exclusives/FDA-Approves-Ramucirumab-in-Gastric-Cancer-and-GEJ-AdenocarcinomaOnclive articlesusMon, 21 Apr 2014 17:31:14 EDTOnclive<![CDATA[Emerging Breakthroughs in Cancer Care: Toward a Revolution?]]>http://www.onclive.com/publications/obtn/2014/April-2014/Emerging-Breakthroughs-in-Cancer-Care-Toward-a-RevolutionOnclive articlesusMon, 21 Apr 2014 16:38:21 EDTOnclive<![CDATA[AR Findings Highlight Detailed Tumor-Profiling Study]]>http://www.onclive.com/publications/Oncology-live/2014/April-2014/AR-Findings-Highlight-Detailed-Tumor-Profiling-StudyOnclive articlesusMon, 21 Apr 2014 09:52:01 EDTOnclive<![CDATA[New MRD Assay Helps Move Testing Forward in Multiple Myeloma Research]]>http://www.onclive.com/publications/Oncology-live/2014/April-2014/New-MRD-Assay-Helps-Move-Testing-Forward-in-Multiple-Myeloma-ResearchOnclive articlesusFri, 18 Apr 2014 17:23:23 EDTOnclive<![CDATA[Durable T-VEC Responses Fail to Prolong Survival in Updated Analysis]]>http://www.onclive.com/web-exclusives/Durable-T-VEC-Responses-Fail-to-Prolong-Survival-in-Updated-AnalysisOnclive articlesusFri, 18 Apr 2014 10:22:01 EDTOnclive<![CDATA[FDA Approves First-Line Ofatumumab for Fludarabine-Ineligble Patients With CLL]]>http://www.onclive.com/web-exclusives/FDA-Approves-First-Line-Ofatumumab-for-Chemotherapy-Ineligble-Patients-With-CLLOnclive articlesusThu, 17 Apr 2014 16:05:37 EDTOnclive<![CDATA[Epizyme Maintains Independence, Advances HMT-Inhibitor Platform]]>http://www.onclive.com/publications/obtn/2014/April-2014/Epizyme-Maintains-Independence-Advances-HMT-Inhibitor-PlatformOnclive articlesusThu, 17 Apr 2014 09:03:29 EDTOnclive OncLive - Bringing the Oncology Community Together